34 studies found for:    " September 17, 2008":" October 17, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" September 17, 2008":" October 17, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem
Conditions: Influenza;   Acquired Immune Deficiency Syndrome;   HIV Infections
Intervention: Biological: Mesotherapy
2 Terminated
Has Results
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Condition: Acquired Immune Deficiency Syndrome
Interventions: Drug: Lopinavir 400 mg/ritonavir 100 mg;   Drug: Efavirenz
3 Terminated Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
Condition: HIV Infections
Intervention: Drug: Angiotensin 1-7
4 Active, not recruiting HIV Risk Reduction in Youth in the Bahamas
Condition: HIV Infections
Interventions: Behavioral: FOYC;   Behavioral: Goal for it (GFI);   Behavioral: Wonderous Wetlands;   Behavioral: Caribbean Informed Parents and Children Together (CImPACT);   Behavioral: Bahamian Focus on Older Youth (BFOOY);   Behavioral: Health and Family Life Curriculum (HFLE)
5 Completed Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China
Conditions: Opiate Dependence;   HIV Infections
Interventions: Behavioral: Behavioral Drug and HIV Risk Reduction Counseling (BDRC);   Behavioral: Drug counseling
6 Completed Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 1 P inhibitor + 2 nucleoside reverse transcriptase inhibitor or 1 non-nucleoside reverse transcriptase inhibitor + 2 nucleoside reverse transcriptase inhibitor
7 Recruiting Analysis of HIV-1 Replication During Antiretroviral Therapy
Condition: HIV Infection
Intervention:
8 Completed
Has Results
Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
Condition: HIV Infections
Intervention: Drug: Low dose Kaletra tablets
9 Completed
Has Results
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Condition: HIV Infections
Interventions: Drug: ATV/r;   Drug: DRV/r
10 Completed
Has Results
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Hyper-immune Bovine Colostrum;   Other: raltegravir placebo;   Other: Hyper-immune Bovine Colostrum placebo;   Drug: raltegravir and hyper-immune bovine colostrum
11 Completed Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?
Conditions: Latent Tuberculosis;   HIV Infections
Intervention: Other: T-Spot.TB test
12 Completed Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir and truvada;   Drug: Atazanavir, Norvir and Truvada
13 Completed PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection
Condition: HIV Infection
Interventions: Biological: PENNVAX-B;   Biological: GENEVAX IL-12-4532;   Biological: PLACEBO;   Biological: IL-15 adjuvant
14 Completed Efficacy of Influenza Vaccine in HIV Infected Adults
Conditions: HIV;   Influenza;   Vaccination;   HIV Infections
Intervention: Biological: MUTAGRIP
15 Completed
Has Results
A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)
Condition: Human Immunodeficiency Virus
Intervention: Drug: Comparator: raltegravir
16 Completed GSK1349572 Drug Interaction Study With Protease Inhibitors
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
17 Unknown  An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin
Conditions: HIV Infection;   Tuberculosis
Intervention: Drug: Rifampin
18 Completed Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Vicriviroc
19 Active, not recruiting Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism
Condition: HIV Infections
Interventions: Drug: Tenofovir + emtricitabine + efavirenz;   Drug: Tenofovir + emtricitabine + lopinavir/ritonavir
20 Completed
Has Results
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
Condition: HIV
Interventions: Drug: ritonavir;   Drug: darunavir;   Drug: emtricitabine [FTC]/tenofovir [TDF];   Drug: atazanavir

Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results
Indicates status has not been verified in more than two years